Skip to content
U.S. Transhumanist Party – Official Website
  • Home
  • Posts
  • Values
  • Platform
  • Leadership
  • Advisors
  • Candidates
  • Highlights
  • FAQ
  • States & Allies
  • Free Membership
  • Facebook
  • Twitter
  • Search Icon

U.S. Transhumanist Party – Official Website

U.S. Transhumanist Party – PUTTING SCIENCE, HEALTH, & TECHNOLOGY AT THE FOREFRONT OF AMERICAN POLITICS

Scientists Identify Genes Implicated in the High Regenerative Capacity of Embryos and ESCs – Press Release by Biogerontology Research Foundation

Scientists Identify Genes Implicated in the High Regenerative Capacity of Embryos and ESCs – Press Release by Biogerontology Research Foundation

January 18, 2018 Biogerontology Research Foundation Comments 0 Comment

Biogerontology Research Foundation


CREDIT: AGEX THERAPEUTICS, INSILICO MEDICINE & THE BIOGERONTOLOGY RESEARCH FOUNDATION

Below is a press release by Biogerontology Research Foundation on the regenerative capacity of embryos and embryonic stem cells. This press release was originally published here.

~ Kenneth Alum, Director of  Publication, U.S. Transhumanist Party, January 18, 2018

 

Friday, January 12, 2018, London, UK: Researchers at Insilico Medicine, AgeX Therapeutics and the Biogerontology Research Foundation have published a landmark study titled “Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells” in the journal Oncotarget.

In the study, researchers used deep-learning techniques to analyze gene expression data in embryonic stem cell (ESC) lines at varying stages of development in order to characterize the gene expression profile of cells right at the boundary of the embryonic-fetal transition, when embryos become fetuses and experience a remarkable reduction in their regenerative capacity. In essence, the study’s objective was to hone in on those genes responsible for the remarkable regenerative capacities of embryos and ESCs.

“This is another important step in the progress of Insilico Medicine and indicates that its suite of products is developing rapidly, with significant commercial revenues not far off,” said Jim Mellon, Trustee of the Biogerontology Research Foundation, Chairman of Juvenescence Limited and a key partner of Insilico Medicine.

Mimicking the gene expression profile of cells prior to the embryonic fetal transition in adult tissues and organs is the concept underlying one of the central and most ambitious therapeutic modalities being pursued by AgeX Therapeutics, namely induced Tissue Regeneration (iTR). Therapeutic elaboration of the insights derived from this study could pave the way for in-situ tissue regeneration, and its application to ageing and age-related disease.

“induced Tissue Regeneration (iTR) is one of the most promising therapeutic modalities for enabling in-situ tissue regeneration proposed to date, and one that is likely to bring substantial healthspan-extending effects if implemented. This landmark study paves the way toward that bright future. Interestingly, in its identification of COX7A1 as one of the genes implicated in the remarkable regenerative potential of embryos and ESCs, the study also extends the purview of these findings to novel potential cancer therapies as well,” said Franco Cortese, Deputy Director of the Biogerontology Research Foundation.

The authors also developed effective methods of deriving biologically-relevant information from these profiles, identifying the most interesting genes characterizing the regenerative capacity of ESCs, and performed additional experimental validation to support the findings of the study’s deep learning analysis. Interestingly, one of the genes implicated in the embryonic-fetal transition that the study identified, COX7A1, is dysregulated in a diverse array of cancer types, including breast, lung, kidney, bone and muscle. As such, the results of this study could be used create novel cancer therapies as well.

“AI is quickly becoming the main driver of progress in so many fields of science, technology and human endeavor that it is easy for one to lose count. From healthcare to finance to governance, AI is galvanizing rapid paradigm shifts all around us. Insilico Medicine is rapidly establishing themselves as the leader of AI for longevity, and the combination of their deep-learning expertise with the assets for expert experimental validation and interpretation possessed by AgeX Therapeutics is a partnership that has yielded significant synergistic results in using AI to yield novel insights into the biology of aging and charting the path toward next generation healthspan-extending therapies” said Dmitry Kaminskiy, Managing Trustee of the Biogerontology Research Foundation.

###

Paper Reference: West M, Labat I, Sternberg H, Larocca D, Nasonkin I, Chapman K, Singh R, Makarev E, Aliper A, Kazennov A, Alekseenko A, Shuvalov N, Cheskidova E, Alekseev A, Artemov A, Putin E, Mamoshina P, Pryanichnikov P, Larocca J, Copeland K, Izumchenko E, Korzinkin M and Zhavoronkov A. Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells, Oncotarget. 2017; in press, https://doi.org/10.18632/oncotarget.23748

About the Biogerontology Research Foundation:

The Biogerontology Research Foundation is a UK non-profit research foundation and public policy center seeking to fill a gap within the research community, whereby the current scientific understanding of the ageing process is not yet being sufficiently exploited to produce effective medical interventions. The BGRF funds and conducts research which, building on the body of knowledge about how ageing happens, aims to develop biotechnological interventions to remediate the molecular and cellular deficits which accumulate with age and which underlie the ill-health of old age. Addressing ageing damage at this most fundamental level will provide an important opportunity to produce the effective, lasting treatments for the diseases and disabilities of ageing, required to improve quality of life in the elderly. The BGRF seeks to use the entire scope of modern biotechnology to attack the changes that take place in the course of ageing, and to address not just the symptoms of age-related diseases but also the mechanisms of those diseases.

About Insilico Medicine, Inc.:

Insilico Medicine, Inc. is a bioinformatics company located at the Emerging Technology Centers in Baltimore with R&D resources in 6 countries. The company is widely recognized by the industry for applying next-generation artificial intelligence technology to drug discovery and aging research. For its pioneering work in the applications of Generative Adversarial Networks (GANs) and Reinforcement Learning (RL) and collaborations with the pharmaceutical companies, it was selected as one of the Top 100 AI companies 2018 by CB Insights and Top 5 AI companies for social impact 2017 by NVIDIA. The company pursues internal drug discovery programs in cancer, dermatological, metabolic and CNS diseases, sarcopenia, fibrosis and senescence. Company website: http://www.insilico.com

About AgeX Therapeutics:

AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX), is a biotechnology company applying technology relating to cellular immortality and regenerative biology to aging and age-related diseases. The company has three initial areas of product development: pluripotent stem-cell-derived brown adipocytes (AGEX-BAT1); vascular progenitors (AGEX-VASC1); and induced Tissue Regeneration (iTR). Initial planned indications for these products are Type 2 diabetes, cardiac ischemia, and tissue regeneration respectively. For more information, please visit http://www.agexinc.com or connect with the company on Twitter or Facebook.


Press Releases
AgeX Therapeutics, aging, AI, Artificial Intelligence, BGRF, Biogerontology Research Foundation, cellular immortality, COX7A1, Deep learning, disease, Dmitry Kaminskiy, drug discovery, embryonic stem cell, embryonic-fetal transition, embryos, Franco Cortese, gene, Generative Adversarial Networks, Insilico Medicine, Jim Mellon, life extension, longevity, regenerative biology, Reinforcement Learning, rejuvenation, research, Tissue Regeneration, vascular progenitors

Post navigation

PREVIOUS
Pluslectic – The Dialectic of Positive Feedback – Article by Pedro Villanueva
NEXT
Concrete Transhumanism – An Overview of Emerging Instantiations and the Transhuman Present Project

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Social Media

Constitution of the U.S. Transhumanist Party

Transhumanist Bill of Rights – Version 3.0

U.S. Transhumanist Party Facebook Feed

Free Transhumanist Symbols

Guidelines for Community Conduct

SUBMIT A POST

Subject Categories

    - Life Extension
    - Artificial Intelligence
    - Space Colonization
    - Robotics
    - Biotechnology
    - Nanotechnology
    - Autonomous Vehicles
    - 3D Printing
    - Cryptocurrencies
    - Vertical Farming
    - Universal Basic Income
    - Existential Risk
    - Rationality

Hashtags

    #USTranshumanistParty, #TranshumanistParty, #TranshumanistPolitics, #TomRoss2024, #RossTwedt2024

Recent Posts

  • MIND THE GAP: Bridging the Generation Gap in Longevity Science – Article by Tom Ross
  • U.S. Transhumanist Party Virtual Enlightenment Salon with Michael Rae – August 6, 2023
  • U.S. Transhumanist Party Virtual Enlightenment Salon with Adam Gries – August 13, 2023
  • U.S. Transhumanist Party Report from Longevity Summit Dublin 2023 – August 20, 2023
  • The U.S. Transhumanist Party Urges You to Sign the Dublin Longevity Declaration
  • U.S. Transhumanist Party Virtual Enlightenment Salon – USTP Officers’ Perspectives on Longevity
  • U.S. Transhumanist Party Virtual Enlightenment Salon with Eleanor Davies – September 3, 2023
  • U.S. Transhumanist Party Virtual Enlightenment Salon with Anastasia Egorova – September 10, 2023
  • U.S. Transhumanist Party Virtual Enlightenment Salon with David Patterson – September 17, 2023
  • U.S. Transhumanist Party Enlightenment Salon with Zack Varkaris / Austin Biotec – September 24, 2023
  • U.S. Transhumanist Party International Longevity Day Virtual Enlightenment Salon – October 1, 2023
  • Art Ramon Appointed as Chairman of Arizona Transhumanist Party as David Shumaker Transitions to Emeritus Role
  • RADICAL LIFE SUBTRACTION: Navigating An Uncomfortable Discourse – Article by Tom Ross
  • THE WA.I.TER RULE: Unveiling True Character Through AI Interactions – Article by Tom Ross
  • “PLAYING GOD” ACCUSATION: Unraveling the Controversy Surrounding Transhumanism – Article by Tom Ross
  • CONSPIRACY CAMPAIGN: Leaning into the Unconventional – Article by Tom Ross
  • Ending Aging Forum 2023 – Announcement by SENS Research Foundation
  • U.S. Transhumanist Party Virtual Enlightenment Salon with Miguel Conner – July 16, 2023
  • U.S. Transhumanist Party Virtual Enlightenment Salon with Brent Nally – July 2, 2023
  • U.S. Transhumanist Party Stream – Nigerian Student Tech Innovators: Nonso Nolly and Frederick Onwuka

Recent Comments

  • Dan Elton on Five Misconceptions About Radical Life Extension – Article by Arjun Khemani
  • CCRN on Five Misconceptions About Radical Life Extension – Article by Arjun Khemani
  • Vladimir Shakirov on U.S. Transhumanist Party General Discussion Thread for 2023
  • Zach Richardson on Five Misconceptions About Radical Life Extension – Article by Arjun Khemani
  • Jason Mallory on U.S. Transhumanist Party 2023 Electronic Primary Results – Tom Ross Endorsed as Candidate for President of the United States, Daniel Twedt Selected as Candidate for Vice-President

Archives

  • October 2023 (11)
  • September 2023 (6)
  • August 2023 (1)
  • July 2023 (4)
  • May 2023 (3)
  • April 2023 (3)
  • March 2023 (2)
  • February 2023 (12)
  • January 2023 (24)
  • December 2022 (2)
  • November 2022 (2)
  • October 2022 (3)
  • August 2022 (3)
  • July 2022 (2)
  • May 2022 (6)
  • March 2022 (3)
  • February 2022 (4)
  • January 2022 (7)
  • December 2021 (11)
  • November 2021 (4)
  • October 2021 (5)
  • September 2021 (2)
  • August 2021 (2)
  • July 2021 (4)
  • June 2021 (2)
  • May 2021 (6)
  • April 2021 (7)
  • March 2021 (4)
  • February 2021 (5)
  • January 2021 (6)
  • December 2020 (10)
  • November 2020 (4)
  • October 2020 (2)
  • September 2020 (1)
  • August 2020 (4)
  • July 2020 (5)
  • June 2020 (6)
  • May 2020 (3)
  • April 2020 (3)
  • March 2020 (6)
  • February 2020 (1)
  • January 2020 (6)
  • December 2019 (3)
  • November 2019 (2)
  • October 2019 (9)
  • September 2019 (10)
  • August 2019 (12)
  • July 2019 (18)
  • June 2019 (17)
  • May 2019 (12)
  • April 2019 (8)
  • March 2019 (12)
  • February 2019 (7)
  • January 2019 (13)
  • December 2018 (9)
  • November 2018 (5)
  • October 2018 (9)
  • September 2018 (5)
  • August 2018 (10)
  • July 2018 (13)
  • June 2018 (14)
  • May 2018 (8)
  • April 2018 (8)
  • March 2018 (10)
  • February 2018 (15)
  • January 2018 (17)
  • December 2017 (8)
  • November 2017 (17)
  • October 2017 (19)
  • September 2017 (11)
  • August 2017 (11)
  • July 2017 (16)
  • June 2017 (15)
  • May 2017 (10)
  • April 2017 (7)
  • March 2017 (8)
  • February 2017 (16)
  • January 2017 (8)
  • December 2016 (6)
  • November 2016 (5)

Categories

  • Allied Projects
  • Announcements
  • Art
  • Candidates
  • Discussion Panels
  • Distributed Computing
  • Exposure Periods
  • Foreign Ambassadors
  • General Discussion
  • Guest Articles
  • Inclusion
  • Interviews
  • Official Ballots
  • Petitions
  • Platform
  • Presentations
  • Press Releases
  • Research
  • Sample Ballots
  • Science Fiction
  • Statements
  • Tolerance
  • Virtual Enlightenment Salons
  • Vote Results
  • Working Groups

Victor Run Virtual Race – June 4-6, 2021

Historical Archive – 2020 U.S. Presidential Ticket – Charlie Kam and Liz Parrish

© 2023   Copyright - U.S. Transhumanist Party - All Rights Reserved | WordPress design: Art Ramon Paintings